Besides its antidiabetic effect, dapagliflozin has also been found to prevent the development of nephropathy, probably by decreasing body weight, uric acid, blood pressure, lipid metabolism, inflammation and improving insulin resistance. This evidence concerns the gene INS and kidney disorder.